Location History:
- L'Hay les Roses, FR (2010)
- Fresnes, FR (2003 - 2011)
Company Filing History:
Years Active: 2003-2011
Title: Sylvie Wentzler: Innovator in Pharmaceutical Chemistry
Introduction
Sylvie Wentzler is a notable inventor based in Fresnes, France. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of kinase inhibitors. With a total of 7 patents to her name, Wentzler's work has the potential to impact various therapeutic areas.
Latest Patents
Wentzler's latest patents include innovative compounds such as pyrrolo(2,3-b) pyridine derivatives, which are designed for pharmaceutical use as kinase inhibitors. These compounds are characterized by specific formulas and are intended for use in treating diseases related to protein kinases. Another significant patent involves bis-azaindole derivatives, which also serve as kinase inhibitors, showcasing her expertise in creating novel pharmaceutical compositions.
Career Highlights
Throughout her career, Wentzler has been associated with Aventis Pharma S.A., where she has played a crucial role in advancing pharmaceutical research. Her work has not only contributed to the scientific community but has also paved the way for new treatment options in medicine.
Collaborations
Wentzler has collaborated with esteemed colleagues such as Conception Nemecek and Corinne Venot, further enhancing her research and development efforts in the pharmaceutical industry.
Conclusion
Sylvie Wentzler's innovative contributions to pharmaceutical chemistry, particularly in the realm of kinase inhibitors, highlight her as a key figure in the field. Her patents and collaborations reflect her commitment to advancing medical science and improving patient outcomes.